Applicability of a Combination of Hemoglobin A1c and Fasting Plasma Glucose in Population-based Prediabetes Screening
Journal of Diabetes, 03/06/2012Okosun IS et al.
The enhanced prevalence of prediabetes using HbA1c+FPG compared with FPG+2hPG calls for the need to redefine at a more basic and a more practical level how to apply HbA1c in screening for prediabetes. A redefined HbA1c that incorporates FPG, age, race/ethnicity and BMI may put forward a better way to use HbA1c in population–based and clinical settings.
Data (n=1376) from the 2007–2008 U.S. National Health and Nutrition Examination Surveys were used for this investigation.
Prediabetes cut points were determined using 5.7–6.4%, 100–125 mg/dl, and 140–199 mg/dl of HbA1c, FPG and 2hPG, respectively.
Concordances between HbA1c and FPG, HbA1c and 2hPG, HbA1c+FPG and FPG+2hPG in screening for undiagnosed prediabetes were determined using sensitivity, specificity, and positive and negative likelihood ratios.
The overall concordance between HbA1c+FPG and FPG+2hPG in screening for prediabetes was high as indicated by sensitivity of 92.4% [95% CI=90.5–94.5]) and specificity of 84.1% [95% CI=81.2–87.0].
The application of HbA1c+FPG was associated with higher prevalence of prediabetes compared to FPG+2hPG.
Compared with FPG+2hPG, screening with HbA1c+FPG was associated with 3.2%, 24.3% and 4.2%relative increased in identification of prediabetes in nondiabetic non–Hispanic Whites, non–Hispanic Blacks and Mexican–Americans, respectively.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.